Health Related Quality of Life in Japanese Patients with Localized Prostate Cancer: Comparative Retrospective Study of Robot-Assisted Laparoscopic Radical Prostatectomy Versus Radiation Therapy
Open Access
- 1 February 2020
- journal article
- research article
- Published by Tottori University Faculty of Medicine in Yonago Acta Medica
- Vol. 63 (1), 55-62
- https://doi.org/10.33160/yam.2020.02.008
Abstract
Background Radical prostatectomy and radiotherapy are standard treatments for localized prostate cancer. When making decisions about treatment, it is important to not only consider medical information such as the patient's age, performance status, and complications, but also the impact on quality of life (QOL) after treatment. Our purpose was to compare health related quality of life (HRQOL) after robot-assisted laparoscopic radical prostatectomy (RARP) versus radiation therapy in Japanese patients with localized prostate cancer retrospectively. Methods Patients with localized prostate cancer receiving RARP or radiotherapy at Tottori University Hospital between October 2010 and December 2014 were enrolled in a retrospective observational study with follow-up for 24 months to December 2016. The Medical Outcome Study 8-Item Short-Form Health Survey was performed before treatment and 1, 3, 6, 12, and 24 months post-treatment. Results Complete responses to the questionnaire were obtained from 154/227 patients receiving RARP, 41/67 patients receiving intensity-modulated radiation therapy, 35/82 patients receiving low dose rate brachytherapy, and 18/28 patients given low dose rate brachytherapy plus external beam radiation therapy. The median physical component summary score of the Medical Outcome Study 8-Item Short-Form Health Survey was significantly lower at 1 month after prostatectomy than radiotherapy, but was similar for both treatments at 3 months, and was significantly higher at 6, 12 and 24 months after prostatectomy. The median mental component summary score was also significantly lower in the prostatectomy group at 1 month, but not from 3 months onwards. Conclusion Our study suggested that HRQOL was inferior at 1 month after RARP, however, recovered at 3 months after RARP and was better than after radiotherapy at 6, 12, and 24 months.Keywords
This publication has 27 references indexed in Scilit:
- Systematic Review and Meta-analysis of Studies Reporting Potency Rates After Robot-assisted Radical ProstatectomyEuropean Urology, 2012
- Who makes the decision regarding the treatment of clinically localized prostate cancer–the patient or physician?Cancer, 2012
- Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical ProstatectomyEuropean Urology, 2012
- Functional Outcomes and Complications Following Radiation Therapy for Prostate Cancer: A Critical Analysis of the LiteratureEuropean Urology, 2012
- High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity DataInternational Journal of Radiation Oncology*Biology*Physics, 2011
- A cohort study investigating patient expectations and satisfaction outcomes in men undergoing robotic assisted radical prostatectomyInternational Urology and Nephrology, 2010
- High-Dose-Rate Brachytherapy of a Single Implant With Two Fractions Combined With External Beam Radiotherapy for Hormone-Naive Prostate CancerInternational Journal of Radiation Oncology*Biology*Physics, 2008
- A Nomogram Predicting 10-Year Life Expectancy in Candidates for Radical Prostatectomy or Radiotherapy for Prostate CancerJournal of Clinical Oncology, 2007
- Quality-of-Life Outcomes in Men Treated for Localized Prostate CancerJAMA, 1995
- Quality-of-life outcomes in men treated for localized prostate cancerJAMA, 1995